uk/emc/medicine/18447/SPC/TYSABRI+300+mg+concentrate+for+solution+for+infusion/]", "section_type": "REF", "source": "Natalizumab summary of product characteristics", "type": "ref", "year": "2011"}, "text": "", "sentences": [], "annotations": [], "relations": []}, {"offset": 27254, "infons": {"fpage": "889", "lpage": "910", "name_0": "surname:Polman;given-names:CH", "name_1": "surname:O'Connor;given-names:PW", "name_10": "surname:Toal;given-names:M", "name_11": "surname:Lynn;given-names:F", "name_12": "surname:Panzara;given-names:MA", "name_13": "surname:Sandrock;given-names:AW", "name_2": "surname:Havrdova;given-names:E", "name_3": "surname:Hutchinson;given-names:M", "name_4": "surname:Kappos;given-names:L", "name_5": "surname:Miller;given-names:DH", "name_6": "surname:Phillips;given-names:JT", "name_7": "surname:Lublin;given-names:FD", "name_8": "surname:Giovannoni;given-names:G", "name_9": "surname:Wajgt;given-names:A", "pub-id_pmid": "16510742", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "354", "year": "2006"}, "text": "A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 27341, "infons": {"fpage": "1390", "lpage": "1401", "name_0": "surname:Miller;given-names:DH", "name_1": "surname:Soon;given-names:D", "name_10": "surname:Kappos;given-names:L", "name_11": "surname:Hutchinson;given-names:M", "name_12": "surname:Havrdova;given-names:E", "name_13": "surname:Lublin;given-names:FD", "name_14": "surname:Giovannoni;given-names:G", "name_15": "surname:Wajgt;given-names:A", "name_16": "surname:Rudick;given-names:R", "name_17": "surname:Lynn;given-names:F", "name_18": "surname:Panzara;given-names:MA", "name_19": "surname:Sandrock;given-names:AW", "name_2": "surname:Fernando;given-names:KT", "name_3": "surname:MacManus;given-names:DG", "name_4": "surname:Barker;given-names:GJ", "name_5": "surname:Yousry;given-names:TA", "name_6": "surname:Fisher;given-names:E", "name_7": "surname:O'Connor;given-names:PW", "name_8": "surname:Phillips;given-names:JT", "name_9": "surname:Polman;given-names:CH", "pub-id_pmid": "17452584", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "68", "year": "2007"}, "text": "MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS", "sentences": [], "annotations": [], "relations": []}, {"offset": 27415, "infons": {"fpage": "911", "lpage": "923", "name_0": "surname:Rudick;given-names:RA", "name_1": "surname:Stuart;given-names:WH", "name_10": "surname:Panzara;given-names:MA", "name_11": "surname:Sandrock;given-names:AW", "name_2": "surname:Calabresi;given-names:PA", "name_3": "surname:Confavreux;given-names:C", "name_4": "surname:Galetta;given-names:SL", "name_5": "surname:Radue;given-names:EW", "name_6": "surname:Lublin;given-names:FD", "name_7": "surname:Weinstock-Guttman;given-names:B", "name_8": "surname:Wynn;given-names:DR", "name_9": "surname:Lynn;given-names:F", "pub-id_pmid": "16510745", "section_type": "REF", "source": "N Engl J Med", "type": "ref", "volume": "354", "year": "2006"}, "text": "Natalizumab plus interferon beta-1 for relapsing multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 27483, "infons": {"fpage": "806", "lpage": "812", "name_0": "surname:Goodman;given-names:AD", "name_1": "surname:Rossman;given-names:H", "name_10": "surname:Panzara;given-names:MA", "name_11": "surname:Sandrock;given-names:AW", "name_2": "surname:Bar-Or;given-names:A", "name_3": "surname:Miller;given-names:A", "name_4": "surname:Miller;given-names:DH", "name_5": "surname:Schmierer;given-names:K", "name_6": "surname:Lublin;given-names:F", "name_7": "surname:Khan;given-names:O", "name_8": "surname:Bormann;given-names:NM", "name_9": "surname:Yang;given-names:M", "pub-id_pmid": "19255407", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "72", "year": "2009"}, "text": "GLANCE: results of a phase II, randomized, double-blind, placebo-controlled study", "sentences": [], "annotations": [], "relations": []}, {"offset": 27565, "infons": {"fpage": "254", "lpage": "260", "name_0": "surname:Havrdova;given-names:E", "name_1": "surname:Galetta;given-names:S", "name_10": "surname:Pace;given-names:A", "name_11": "surname:Kim;given-names:R", "name_12": "surname:Hyde;given-names:R", "name_2": "surname:Hutchinson;given-names:M", "name_3": "surname:Stefoski;given-names:D", "name_4": "surname:Bates;given-names:D", "name_5": "surname:Polman;given-names:CH", "name_6": "surname:O'Connor;given-names:PW", "name_7": "surname:Giovannoni;given-names:G", "name_8": "surname:Phillips;given-names:JT", "name_9": "surname:Lublin;given-names:FD", "pub-id_pmid": "19201654", "section_type": "REF", "source": "Lancet Neurol", "type": "ref", "volume": "8", "year": "2009"}, "text": "Effect of natalizumab on clinical an